Capivasertib
Overview
Capivasertib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL2325741).
API suppliers (1)
Suppliers of Capivasertib evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
1 of 1 holds a GMP certificate on record in the EU or UK registers
- Formosa Laboratories, Inc.Taiwan1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (2 approved US products), the latest listed US patent on Capivasertib expires 16 Apr 2033 and exclusivity 12 Jun 2029. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide
- Canonical SMILES
- C1CN(CCC1(C(=O)N[C@@H](CCO)C2=CC=C(C=C2)Cl)N)C3=NC=NC4=C3C=CN4
- InChIKey
- JDUBGYFRJFOXQC-KRWDZBQOSA-N
Do you supply Capivasertib? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.